Skip to content
VuFind
  • Login
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Advanced
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
Cover Image

Saved in:
Bibliographic Details
Main Author: Iskandar Idris
Format: Artículo Open Access
Published: Wiley 2024
Subjects:
Diabetes, Obesity and Metabolism Now
Online Access:https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1002/doi2.109
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Holdings
  • Description
  • Table of Contents
  • Comments
  • Similar Items
  • Staff View
Be the first to leave a comment!
You must be logged in first

Similar Items

  • Potential role of glucagon like peptide (GLP)‐1 receptor agonist to reduce risk of colorectal cancer?
    by: Iskandar Idris
    Published: (2024)
  • The glucagon like peptide‐1 linked to nonarteritic anterior ischemic optic neuropathy
    by: Iskandar Idris
    Published: (2024)
  • Glucagon like peptide‐1 (GLP‐1) therapy is associated with reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes with chronic liver disease
    by: Iskandar Idris
    Published: (2024)
  • Real world data showed that the dual GLP gip agonist, Tirzepatide is associated with lower mortality, cardiovascular events and adverse kidney events compared with GLP‐1 analogue
    by: Iskandar Idris
    Published: (2024)
  • Real world study provided reassurance of the safety of GLP‐1 therapy on mental health and suicide risk
    by: Iskandar Idris
    Published: (2024)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs